Literature DB >> 24554745

Rapid molecular detection of inducible macrolide resistance in Mycobacterium chelonae and M. abscessus strains: a replacement for 14-day susceptibility testing?

Kimberly E Hanson1, E Susan Slechta, Haleina Muir, Adam P Barker.   

Abstract

The erm(41) gene causes inducible macrolide resistance in Mycobacterium abscessus but not Mycobacterium chelonae. erm(41) sequencing of 285 M. abscessus and 45 M. chelonae isolates was compared to 14-day susceptibility; agreement percentages were 98.9% and 100%, respectively. Extended incubation may not be necessary for M. chelonae, and the erm(41) genotype is a useful adjunct for M. abscessus.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24554745      PMCID： PMC3993676          DOI： 10.1128/JCM.03464-13

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  17 in total

1.  Mycobacterium massiliense is differentiated from Mycobacterium abscessus and Mycobacterium bolletii by erythromycin ribosome methyltransferase gene (erm) and clarithromycin susceptibility patterns.

Authors:  Hee-Youn Kim; Byoung Jun Kim; Yoonwon Kook; Yeo-Jun Yun; Jeong Hwan Shin; Bum-Joon Kim; Yoon-Hoh Kook
Journal:  Microbiol Immunol       Date:  2010-06       Impact factor: 1.955

Review 2.  An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases.

Authors:  David E Griffith; Timothy Aksamit; Barbara A Brown-Elliott; Antonino Catanzaro; Charles Daley; Fred Gordin; Steven M Holland; Robert Horsburgh; Gwen Huitt; Michael F Iademarco; Michael Iseman; Kenneth Olivier; Stephen Ruoss; C Fordham von Reyn; Richard J Wallace; Kevin Winthrop
Journal:  Am J Respir Crit Care Med       Date:  2007-02-15       Impact factor: 21.405

Review 3.  Mycobacterium abscessus: an emerging rapid-growing potential pathogen.

Authors:  Björn Petrini
Journal:  APMIS       Date:  2006-05       Impact factor: 3.205

4.  Clinical significance of differentiation of Mycobacterium massiliense from Mycobacterium abscessus.

Authors:  Won-Jung Koh; Kyeongman Jeon; Nam Yong Lee; Bum-Joon Kim; Yoon-Hoh Kook; Seung-Heon Lee; Young Kil Park; Chang Ki Kim; Sung Jae Shin; Gwen A Huitt; Charles L Daley; O Jung Kwon
Journal:  Am J Respir Crit Care Med       Date:  2010-09-10       Impact factor: 21.405

5.  Assessment of clarithromycin susceptibility in strains belonging to the Mycobacterium abscessus group by erm(41) and rrl sequencing.

Authors:  Sylvaine Bastian; Nicolas Veziris; Anne-Laure Roux; Florence Brossier; Jean-Louis Gaillard; Vincent Jarlier; Emmanuelle Cambau
Journal:  Antimicrob Agents Chemother       Date:  2010-12-06       Impact factor: 5.191

6.  Genetic basis for clarithromycin resistance among isolates of Mycobacterium chelonae and Mycobacterium abscessus.

Authors:  R J Wallace; A Meier; B A Brown; Y Zhang; P Sander; G O Onyi; E C Böttger
Journal:  Antimicrob Agents Chemother       Date:  1996-07       Impact factor: 5.191

7.  A novel gene, erm(41), confers inducible macrolide resistance to clinical isolates of Mycobacterium abscessus but is absent from Mycobacterium chelonae.

Authors:  Kevin A Nash; Barbara A Brown-Elliott; Richard J Wallace
Journal:  Antimicrob Agents Chemother       Date:  2009-01-26       Impact factor: 5.191

8.  Inaccuracy of single-target sequencing for discriminating species of the Mycobacterium abscessus group.

Authors:  Edouard Macheras; Anne-Laure Roux; Fabienne Ripoll; Valérie Sivadon-Tardy; Cristina Gutierrez; Jean-Louis Gaillard; Beate Heym
Journal:  J Clin Microbiol       Date:  2009-06-10       Impact factor: 5.948

9.  Cohort study of molecular identification and typing of Mycobacterium abscessus, Mycobacterium massiliense, and Mycobacterium bolletii.

Authors:  Adrian M Zelazny; Jeremy M Root; Yvonne R Shea; Rhonda E Colombo; Isdore C Shamputa; Frida Stock; Sean Conlan; Steven McNulty; Barbara A Brown-Elliott; Richard J Wallace; Kenneth N Olivier; Steven M Holland; Elizabeth P Sampaio
Journal:  J Clin Microbiol       Date:  2009-05-06       Impact factor: 5.948

10.  Activities of four macrolides, including clarithromycin, against Mycobacterium fortuitum, Mycobacterium chelonae, and M. chelonae-like organisms.

Authors:  B A Brown; R J Wallace; G O Onyi; V De Rosas; R J Wallace
Journal:  Antimicrob Agents Chemother       Date:  1992-01       Impact factor: 5.191
View more
  11 in total

1.  Whole-Genome Sequencing for Predicting Clarithromycin Resistance in Mycobacterium abscessus.

Authors:  Samuel Lipworth; Natasha Hough; Laura Leach; Marcus Morgan; Katie Jeffery; Monique Andersson; Esther Robinson; E Grace Smith; Derrick Crook; Tim Peto; Timothy Walker
Journal:  Antimicrob Agents Chemother       Date:  2018-12-21       Impact factor: 5.191

Review 2.  Antimycobacterial Susceptibility Testing of Nontuberculous Mycobacteria.

Authors:  Barbara A Brown-Elliott; Gail L Woods
Journal:  J Clin Microbiol       Date:  2019-09-24       Impact factor: 5.948

3.  Absence of a functional erm gene in isolates of Mycobacterium immunogenum and the Mycobacterium mucogenicum group, based on in vitro clarithromycin susceptibility.

Authors:  Barbara A Brown-Elliott; Kimberly Hanson; Sruthi Vasireddy; Elena Iakhiaeva; Kevin A Nash; Ravikiran Vasireddy; Nicholas Parodi; Terry Smith; Martha Gee; Anita Strong; Adam Barker; Samuel Cohen; Haleina Muir; E Susan Slechta; Richard J Wallace
Journal:  J Clin Microbiol       Date:  2015-01-07       Impact factor: 5.948

4.  Management of a Mycobacterium immunogenum infection of a peritoneal dialysis catheter site.

Authors:  Abhishek Shenoy; Walid El-Nahal; McCall Walker; Tushar Chopra; Gregory Townsend; Scott Heysell; Joshua Eby
Journal:  Infection       Date:  2018-08-21       Impact factor: 3.553

5.  Drug susceptibility patterns of rapidly growing mycobacteria isolated from skin and soft tissue infections in Venezuela.

Authors:  Omaira Da Mata-Jardín; Alejandro Angulo; Margarita Rodríguez; Sandra Fernández-Figueiras; Jacobus H de Waard
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-11-18       Impact factor: 3.267

Review 6.  Mycobacterium abscessus Complex Infections in Children: A Review.

Authors:  Arick P Sabin; Patricia Ferrieri; Susan Kline
Journal:  Curr Infect Dis Rep       Date:  2017-10-05       Impact factor: 3.725

7.  A Molecular-Beacon-Based Multiplex Real-Time PCR Assay To Distinguish Mycobacterium abscessus Subspecies and Determine Macrolide Susceptibility.

Authors:  Salvatore A E Marras; Liang Chen; Elena Shashkina; Rebecca M Davidson; Michael Strong; Charles L Daley; Barry N Kreiswirth
Journal:  J Clin Microbiol       Date:  2021-07-19       Impact factor: 5.948

8.  Dual β-Lactam Combinations Highly Active against Mycobacterium abscessus Complex In Vitro.

Authors:  R Pandey; L Chen; C Manca; S Jenkins; L Glaser; C Vinnard; G Stone; J Lee; B Mathema; E L Nuermberger; R A Bonomo; B N Kreiswirth
Journal:  mBio       Date:  2019-02-12       Impact factor: 7.786

9.  Recurrence of cutaneous Mycobacterium chelonae infection: A case report.

Authors:  Anaïs DuBow; Meggie Morand; Delphine Désy; Mark Krasny
Journal:  SAGE Open Med Case Rep       Date:  2019-04-26

10.  Disseminated Mycobacterial Infection After International Medical Tourism.

Authors:  Brian A Kendall; Adam P Barker; Jason C Hadley; Scott R Florell; Kevin L Winthrop
Journal:  Open Forum Infect Dis       Date:  2015-04-17       Impact factor: 3.835
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.